Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency

J Investig Allergol Clin Immunol. 2019 Dec;29(6):470-471. doi: 10.18176/jiaci.0450.

Authors

G Tessarin¹, M P Bondioni², S Rossi¹, L Palumbo³, A Soresina³, R Badolato¹, A Plebani¹, V Lougaris¹

Affiliations

¹ Pediatrics Clinic, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
² Pediatric Radiology, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
³ Pediatrics Clinic, ASST-Spedali Civili of Brescia, Brescia, Italy.

PMID: 31825316
DOI: 10.18176/jiaci.0450

No abstract available

Keywords: B cell; Common variable immunodeficiency; Granulomatous lymphocytic interstitial lung disease; Rituximab; Tertiary lymphoid structures.

Publication types

Case Reports

MeSH terms

Adult
Common Variable Immunodeficiency / drug therapy*
Female
Humans
Immunologic Factors / therapeutic use*
Lung Diseases, Interstitial / drug therapy*
Rituximab / therapeutic use*

Substances

Immunologic Factors
Rituximab